Envision is the new in-office standard revolutionizing procedures in small and delicate areas. This ground breaking, nonsurgical device, allows for safe and highly efficacious procedures in the skin and subdermal layers of the periorbital region. With Envision, practitioners deliver energy-based therapies to improve patient quality of life.
KEY BENEFITS
•
Envision deploys multiple complementary modalities which work synergistically:
Forma-I is Health Canada certified to address the symptoms of dry eye disease caused by Meibomian Gland Dysfunction (MGD). It is intended for use in the periorbital area and eyelids, and relieves inflammation of meibomian glands and eye irritation*. Forma-I is FDA cleared for the temporary improvement of local blood circulation.
*Health Canada certified indications for use.
Lumecca, with the Lumecca-I adaptor, delivers precise, targeted IPL procedures to treat rosacea-related inflammatory conditions. Lumecca is FDA cleared for the treatment of benign pigmented epidermal lesions and benign cutaneous vascular lesions, and is optimized for light and dark skin tones.
Morpheus8 is a minimally invasive device for fractional coagulation of subcutaneous tissue. Morpheus8 provides a portfolio of interchangeable microneedling tips to deliver customizable fractional treatments.
